PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Award Highlights Belimed Group's Commitment to Customer Value Enhancement - The
Frost & Sullivan Award Highlights Belimed Group's Commitment to Customer Value Enhancement

 

NewswireToday - /newswire/ - London, United Kingdom, 2010/10/19 - The "2010 Frost & Sullivan European Infection Control Customer Value Enhancement Award," was recently conferred on Belimed Group, one of the leading companies in the European decontamination equipment market.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Innovative and high quality products, coupled with exceptional customer services and key differentiating factors, are signals that Belimed performs exceptionally well in this market. The Frost & Sullivan Award for Customer Value Enhancement is awarded to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. This award recognises the company's inordinate focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and ultimately customer base expansion.

The decontamination equipment market in Western Europe has reached a high level of maturity, with Tier I companies holding about 70% of the total market share. By contrast, Eastern Europe is a primarily price-sensitive market, fed by high demand for premium quality decontamination equipment.

"Due to the large capital investment required for the purchase of decontamination equipment, customer expectations are increasingly focused on product quality and durability," notes Frost & Sullivan Senior Research Analyst Beulah Devadason. "Belimed leverages this trend by promoting itself as a high-quality brand that offers products at competitive prices."

A tradition of continuous innovation represents one of the primary distinguishing factors for Belimed. This is evident by the fact that Belimed Technik GmbH, one of Belimed's four centres of expertise, was recognised as one of the 100 most innovative small and medium-sized companies in Germany.

"Another important feature of Belimed is that decisions about innovations are taken in close cooperation with customers," adds Devadason. "The introduction of the New Machine generation, the H202 low-temperature plasma sterilizer and the automated cleaning, disinfection and drying endoscope reprocessors has helped Belimed establish itself as a top innovator in the market."

Belimed is also preferred for its outstanding value added services. It holds regular training courses for Central Sterile Supply Department (CSSD) staff to enhance their handling of decontamination equipment.

"Internal and external training courses for CSSD staff are one of the most important components in ensuring operational safety," remarks Devadason. "Through these training sessions, Belimed provides CSSD staff with numerous opportunities to safely and effectively handle decontamination systems."

Similarly, the company's success has been enhanced due to its supply of customised service packages to end-users. Flexible and individualised service offerings ensure that a high level of customer satisfaction is continuously maintained.

"Belimed provides consulting and customer support throughout projects, while also covering individual after-sales services," concludes Devadason. "Belimed's clients receive decontamination equipment planning, installation and after-sales services in a quick and timely manner."

The Frost & Sullivan Award for Customer Value Enhancement is awarded to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. This award recognises the company's inordinate focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and ultimately customer base expansion.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Belimed
Belimed (belimed.com), a European company group with headquarters in Switzerland, is one of the worldwide leading companies operating in the area of infection control. Belimed has over 40 years of experience in development, production and marketing of innovative system solutions for cleaning, disinfection and sterilization in the healthcare, pharmaceutical and laboratory sectors and offers the associated services such as servicing and validation. Belimed is a company of the Metall Zug Group and has a workforce of over 900 employees. With a total of 12 Belimed companies throughout Europe, North America and Asia, and many authorised partners, Belimed is represented worldwide by a strong network in over 80 countries.

Belimed Contact:
Sonja Metzger, Manager Marketing Services Belimed Group
T: +41 41 768 96 06 / E: sonja.metzger[.]belimed.com.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Award Highlights Belimed Group's Commitment to Customer Value Enhancement

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan | Belimed Profile
Publisher Contact: Ciara Jamie Connolly 
+44 (0) 207.915.7868 ciara.connolly[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)